Inhibiting LSD1 unlocks retinoid AP-1 programming to activate epithelial immunity and skin tumor suppression
Nina Kuprasertkul(University of Pennsylvania), Brian C. Capell(University of Pennsylvania), Donna M. Brennan-Crispi(Thomas Jefferson University), Laura V. Pinheiro(Cancer Research Institute of the Slovak Academy of Sciences), Julia Chini(Children's Hospital of Philadelphia), John T. Seykora(Cancer Research Institute of the Slovak Academy of Sciences), Stephen M. Prouty(Johnson & Johnson (United States)), David A. Hill(Children's Hospital of Philadelphia), Alison Jaccard(Cancer Research Institute of the Slovak Academy of Sciences), Kathryn E. Wellen(Cancer Research Institute), Cyria Olingou, Alyssa F. Moore(University of Pennsylvania), Shuo Zhang(University of Pennsylvania), Yann Aubert(University of Pennsylvania), Eun-Kyung Ko(University of Pennsylvania), Lydia Bao, Carina A. D'souza, Sijia Huang(Penn Center for AIDS Research), Claudia T. Magahis, Ashley S. Anderson(University of Pennsylvania), Shaun Egolf(University of Pennsylvania)
Cited by 0
Related Papers
Inflammation, stress, and diabetes
|Journal of Clinical Investigation|2005|3.9k
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
|Journal of Clinical Investigation|2012|538
Metabolic and epigenetic regulation of T-cell exhaustion
|Nature Metabolism|2020|443
Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis
|Mucosal Immunology|2009|428
The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism
|Genes & Development|2010|365